111.
Yerushalmy-Feler A, Olbjorn C, Kolho KL, Aloi M, Musto F, Martin-de-Carpi J,
Lozano-Ruf A, Yogev D, Matar M, Scarallo L, Bramuzzo M, de Ridder L, Kang
B, Norden C, Wilson DC, Tzivinikos C, Turner D, Cohen S. Dual Biologic
or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease
(DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of
ESPGHAN. Inflamm Bowel Dis. 2023 Apr 12:izad064. Online ahead of print.
110.
Kim JY, Kim YB, Choi S, Lee YM, Kim HJ, Kim SC, Jang HJ, Choi SY, Yi DY, Lee Y,
Choi YJ, Kang Y, Lee KJ, Hong SJ, Hwang JH, Kwak S, Choe BH, Kang B.
Associations of Polyp Characteristics in Children and Adolescents Presenting
with Less Than Five Colorectal Polyps: A Full Colonoscopy Is Still Required. Gut
Liver. 2022 Sep 2. doi: 10.5009/gnl210404. Online ahead of print.
109.
Lee YM, Lee Y, Choi SY, Kim HJ, Hong SJ, Kang Y, Lee EH, Lee KJ, Choi Y, Yi DY,
Kim S, Kang B. A Nationwide Survey on Gastrointestinal Endoscopy
Practice Patterns among Pediatric Endoscopists in South Korea. Pediatr
Gastroenterol Hepatol Nutr. 2023 Mar;26(2):79-87.
108.
Ju J, Oh HS, Lee YJ, Jung H, Lee JH, Kang B, Choi S, Kim JH, Kim
KO, Chung YJ. Clean mucosal area detection of gastroenterologists versus
artificial intelligence in small bowel capsule endoscopy. Medicine (Baltimore).
2023 Feb 10;102(6):e32883.
107.
Kim YB, Kim JY, Choi S, Lee YM, Choi SY, Kim SC, Jang HJ, Lee Y, Jeong IS, Yi
DY, Kang Y, Lee KJ, Choe BH, Kang B. Fecal Calprotectin Levels
Significantly Correlate with Polyp Size in Children and Adolescents with
Juvenile Colorectal Polyps. Pediatr Gastroenterol Hepatol Nutr. 2023
Jan;26(1):34-42.
106. Lee Y, Choi S, Kang B. Practice
Patterns of Colorectal Polypectomy in Pediatric Endoscopic Specialists in South
Korea: A Nationwide Survey Study. Pediatr Gastroenterol Hepatol Nutr. 2023
Jan;26(1):15-22.
105. Park S, Kang B, Kim S, Choi S, Suh HR, Kim ES, Park JH, Kim MJ, Choe YH, Lee YJ, Park JH, Ryoo E, Koh H, Choe BH. Comparison between Pediatric Crohn's Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study. Gut Liver. 2022;16(6):921-929.
104.
Lee S, Choe BH, Kang B, Kim SC. Nationwide Survey for Pediatric
Gastrostomy Tube Placement in Korea. J Korean Med Sci. 2022;37(40):e291.
103.
Pokhrel RH, Kang B, Timilshina M, Chang JH. AMPK Amplifies
IL2-STAT5 Signaling to Maintain Stability of Regulatory T Cells in Aged Mice.
Int J Mol Sci. 2022;23(20):12384.
102.
Lee SW, Kang B, Choi S, Choe BH, Kim YB, Lee KJ, Kim HJ, Jang HJ,
Choi SY, Yi DY, Choi YJ, Kim JY, Lee EH, Lee YM. The Changes in Trends of Lower
Gastrointestinal Endoscopy Conducted in Children and Adolescents after the
COVID-19 Outbreak in Korea. Medicina (Kaunas). 2022;58(10):1378.
101.
Choi S, Kim ES, Kwon Y, Kim MJ, Choe YH, Choe BH, Kang B. Vedolizumab
Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel
Disease Patients Who Fail a Primary Biologic Agent. J Korean Med Sci.
2022;37(37):e282.
100.
Choi SY, Choi S, Kang B, Choe BH, Lee YJ, Park JH, Kim YB, Kim
JY, Lee K, Lee KJ, Kang KS, Lee YM, Kim HJ, Kang Y, Jang HJ, Yi DY, Hong SJ, Choi
YJ, Hong J, Kim SC. Epidemiological Trends of Pediatric Inflammatory Bowel
Disease in Korea: A Multicenter Study of the Last 3 Years Including the
COVID-19 Era. J Korean Med Sci. 2022;37(37):e279.
99.
Choi SY, Lee KJ, Kim SC, Lee EH, Lee YM, Kim YB, Yi DY, Kim JY, Kang B,
Jang HJ, Hong SJ, Choi YJ, Kim HJ. Cardiac Complications Associated with Eating
Disorders in Children: A Multicenter Retrospective Study. Pediatr Gastroenterol
Hepatol Nutr. 2022;25(5):432-440.
98.
Kim ES, Kang B. Assessment of Medication Adherence and Pharmacist
Intervention Are Important for the Care of Patients with Inflammatory Bowel
Disease. Gut Liver. 2022;16(5):665-666.
97. Choi SY, Kim ES,
Jeon TY, Lee YM, Lee SM, Choe BH, Choe YH, Kang B. Transmural healing
evaluated by magnetic resonance enterography in paediatric patients with
Crohn's disease receiving maintenance treatment with biologics. Aliment
Pharmacol Ther. 2022;56(7):1146-1156.
96.
Atia O, Kang B,
Orlansky-Meyer E, Ledder O, Lev Tzion R, Choi S, Choe BH, Kang Y, Yogev D,
Najara H, Carmon N, Focht G, Shteyer E, Turner D. Existing prediction models of
disease course in pediatric Crohn's disease are poorly replicated in a
prospective inception cohort. J Crohns Colitis. 2022;16(7):1039-1048.
95.
Kwon Y, Kang B,
Kim ES, Choe YH, Kim MJ. Comparison of Ustekinumab Trough Concentrations
Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's
Disease. Ther Drug Monit. 2022;44(4):535-542.
94.
Choi YJ, Park EJ, Lee YM, Kim SC, Kang B,
Lee KJ, Jang HJ, Lee EH, Kim JY, Choi SY, Jin Kim H, Kang Y, Choe BH, Lee J, Yi
DY. Effects of anxiety on sedation among pediatric patients undergoing
esophagogastroduodenoscopy. Clin Child Psychol Psychiatry. 2022;27(3):793-803.
93.
Kang Y, Park H, Choe BH, Kang B.
The Role and Function of Mucins and Its Relationship to Inflammatory Bowel
Disease. Front Med (Lausanne). 2022;9:848344.
92.
Lee JM, Kim RJ, Lim JS, Choi S, Choe BH, Kang B. Eosinophilic Gastritis
With Linear Arrays of Pseudopolyps in the Antrum Treated With Exclusive Enteral
Nutrition. J Pediatr Gastroenterol Nutr. 2022;74(5):e127.
91.
Choi SY, Kang B.
Adalimumab in Pediatric Inflammatory Bowel Disease. Front Pediatr.
2022;10:852580.
90. Kim ES, Choi S, Choi
SY, Park JH, Choe BH, Lee SY, Kim MJ, Choe YH, Kang B.
NUDT15
intermediate metabolisers are associated with lower loss of response in
paediatric Crohn's disease patients treated by combination treatment with
infliximab and azathioprine. Aliment Pharmacol Ther. 2022;55(8):1008-1015.
89. Kim YB, Kim JY, Choi S, Kim HJ, Lee YM, Lee Y,
Jang HJ, Lee EH, Lee KJ, Kim SC, Choi SY, Kang Y, Yi DY, Choi YJ, Choe BH, Kang B. Potential Utility of Fecal Calprotectin in
Discriminating Colorectal Polyps From Other Major Etiologies in Children
Presenting With Isolated Hematochezia. J Korean Med Sci. 2022;37(9):e72.
88. Kim ES, Kang B. Editorial: a paradigm shift in NUDT15
assessment-towards predictive and personalised medicine in Crohn's disease
Authors' reply. Aliment Pharmacol Ther. 2022;55(6):742-743.
87. Jung JH, Choi S, Kang Y, Cho DC, Lee SM, Park
TI, Choe BH, Kim D, Kang
B. Development of
Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab
Therapy: A Case Report With Literature Review. Front Pediatr. 2022;9:802298.
86. Kang
B, Yi DY, Choe BH. Translational
Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and
Management in East Asian Countries. Front Pediatr. 2022;9:809838.
85.
Choe JY, Choi S, Song KH, Jang HJ, Choi KH, Yi DY, Hong SJ, Hwang JH, Cho SM,
Kim YJ, Choe BH, Kang B.
Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the
Daegu-Kyungpook Province From 2017 to 2020. Front Pediatr. 2022;9:810173.
84. Lee YM, Choi S, Choe
BH, Jang HJ, Kim S, Koh H, Kim ES, Kim MJ, Choe YH, Kang B.
Association between Fecal Calprotectin and Mucosal Healing in Pediatric
Patients with Crohn's Disease Who Have Achieved Sustained Clinical Remission
with Anti-Tumor Necrosis Factor Agents. Gut Liver. 2022;16(1):62-70.
83.
Park H, Kim J, Choi S, Suh HR, Moon JE, Kim D, Choi BS, Hwang SK, Kang B,
Choe BH. Case report of compound CFTR variants in Korean siblings with cystic
fibrosis: importance of differentiating cystic fibrosis from inflammatory bowel
disease. Transl Pediatr. 2021;10(11):3104-3109.
82.
Kang B,
Um SH, Yun J, Kim HK, Choe BH, Lee YM. Collagenous gastroduodenocolitis in a
Korean adolescent: first pediatric case report in Asia. Transl Pediatr.
2021;10(11):3096-3103.
81. Hong SJ, Kang B, Hwang JH, Kim YB, Lee YM, Jang HJ, Lee KJ, Kim SC, Kang Y, Kim HJ, Kim JY, Choi YJ, Lee EH, Choi SY, Lee E, Choe BH, Chae SA, Choi S, Suh WS, Song J, Yi DY. The occurrence of infection-related systemic diseases in Korean children and adolescents has decreased after the spread of the COVID-19 pandemic: a multicenter retrospective study. Transl Pediatr. 2021;10(11):2888-2896.
80.
Choi S, Lee HJ, Seo AN, Bae HI, Kwon HJ, Cho CM, Lee SM, Choe BH, Kang B.
Case Report: Development of Type 1 Autoimmune Pancreatitis in an Adolescent
With Ulcerative Colitis Mimicking Pancreatic Cancer. Front Pediatr.
2021;9:791840.
79.
Um SH, Lee SW, Song KH, Lee SM, Choe BH, Lee YM, Kang B. Incidentally Detected
Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease
Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at
Diagnosis
Pediatr Gastroenterol Hepatol Nutr. 2021;24(6):564-570.
78.
Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH, Choe BH, Kang B;
Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Severe Disease
Activity Based on the Paris Classification Is Associated with the Development
of Extraintestinal Manifestations in Korean Children and Adolescents with
Ulcerative Colitis. J Korean Med Sci. 2021;36(44):e278.
77.
Pokhrel RH, Acharya S, Ahn JH, Gu Y, Pandit M, Kim JO, Park YY, Kang B,
Ko HJ, Chang JH. AMPK promotes antitumor immunity by downregulating PD-1 in
regulatory T cells via the HMGCR/p38 signaling pathway. Mol Cancer.
2021;20(1):133.
76.
Kang B, Lee HS, Jeon SW, Park SY, Choi GS, Lee WK, Heo S, Lee DH,
Kim DS. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and
TFPI2 genes in colonic mucosa during colorectal cancer development. Cancer
Biomark. 2021;32(2):231-236.
75.
Kim MJ, Kim E, Kang B, Lee Y, Kang ES, Choe YH. Anti-Saccharomyces
cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal
Healing Is a Useful Marker of Mucosal Damage. Gut Liver. 2021;15(5):763-770
74.
Kim MJ, Kim E, Kang B, Choe YH. Infliximab Therapy for Children
with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down
Strategy. Yonsei Med J. 2021;62(7):608-614.
73.
Kim JY, Lee Y, Choe BH, Kang B. Factors Associated with the
Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with
Inflammatory Bowel Disease. Gut Liver. 2021;15(4):588-598.
72.
Choi S, Choi BS, Choe BH, Kang B. Successful treatment with
vedolizumab in an adolescent with Crohn disease who had developed active
pulmonary tuberculosis while receiving infliximab. Yeungnam Univ J Med. 2021;38(3):251-257.
71.
Pandit M, Acharya S, Gu Y, Seo SU, Kweon MN, Kang B, Chang JH.
Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2
expression to ameliorate DSS-induced colitis. Eur J Immunol.
2021;51(6):1461-1472.
70.
Kim MJ, Kim E, Kang B, Choe YH. Therapeutic Drug Monitoring of
Adalimumab During Long-Term Follow-up in Paediatric Patients with Crohn's
Disease. J Pediatr Gastroenterol Nutr. 2021;72(6):870-876.
69.
Choi SY, Yi DY, Kim SC, Kang B, Choe BH, Lee Y, Lee YM, Lee EH,
Jang HJ, Choi YJ, Kim HJ. Severe Phenotype of Non-alcoholic Fatty Liver Disease
in Pediatric Patients with Subclinical Hypothyroidism: a Retrospective
Multicenter Study from Korea. J Korean Med Sci. 2021;36(20):e137.
68.
Lee YM, Kang B, Kim YB, Kim HJ, Lee KJ, Lee Y, Choi SY, Lee EH,
Yi DY, Jang HJ, Choi YJ, Hong SJ, Kim JY, Kang Y, Kim SC. Procedural Sedation
for Pediatric Upper Gastrointestinal Endoscopy in Korea. J Korean Med Sci.
2021;36(20):e136.
67.
Kang B, Hwang SK, Choi S, Kim ES, Lee SY, Ki CS, Cho EH, Lee JH,
Choe BH. Case report of juvenile polyposis/hereditary hemorrhagic
telangiectasia syndrome: first report in Korea with a novel mutation in the
SMAD4 gene. Transl Pediatr. 2021;10(5):1369-1376.
66.
Lee YM, Ryoo E, Hong J, Kang B, Choe BH, Seo JH, Park JS, Jang
HJ, Lee Y, Chang EJ, Chang JY, Lee HJ, Kim JY, Lee EH, Kim HJ, Chung JY, Choi
YJ, Choi SY, Kim SC, Kang KS, Yi DY, Moon KR, Lee JH, Kim YJ, Yang HR. Nationwide
"Pediatric Nutrition Day" survey on the nutritional status of
hospitalized children in South Korea. Nutr Res Pract. 2021;15(2):213-224.
65.
Choi S, Choe BH, Lee SM, Kang B. Diet Advancement Based on Repeat
Upper Gastrointestinal Endoscopies After Removal of an Esophageal Button
Battery. J Pediatr Gastroenterol Nutr. J Pediatr Gastroenterol Nutr.
2021;72(5):e139
64.
Kim ES, Song JS, Ki CS, Choe YH, Kang B. Development of Crohn's
Disease in a Child With SLC26A3-related Congenital Chloride Diarrhea: Report of
the First Case in East Asia and a Novel Missense Variant. Ann Lab Med.
2021;41(2):255-257.
63. Bae J, Choe BH, Kang
B. Prevention of thiopurine-induced early leukopenia in a Korean
pediatric patient with Crohn's disease who turned out to possess homozygous
mutations in NUDT15 R139C. Yeungnam Univ J Med. 2020;37(4):332-336.
62.
Kim G, Bae J, Kim MJ, Kwon H, Park G, Kim SJ, Choe YH, Kim J, Park SH, Choe BH,
Shin H, Kang B. Delayed Establishment of Gut Microbiota in
Infants Delivered by Cesarean Section. Front Microbiol. 2020 Sep 11;11:2099.
61.
Paek EY, Yi DY, Kang B, Choe BH. Fecal calprotectin as a marker
of gastrointestinal involvement in pediatric Henoch-Schonlein purpura patients:
a retrospective analysis. BMC Pediatr. 2020;20(1):374.
60.
Kang B, Kim TJ, Choi J, Baek SY, Ahn S, Choi R, Lee SY, Choe YH. Adjustment
of azathioprine dose should be based on a lower 6-TGN target level to avoid
leucopenia in NUDT15 intermediate metabolisers. Aliment Pharmacol Ther.
2020;52(3):459-470.
59. Kang B, Jung JH, Park JY, Kim YJ,
Choe BH. Retention of a Wireless Endoscopic Capsule in the Meckel Diverticulum
of a 12-Year-old Boy. J Pediatr Gastroenterol Nutr. 2020;71(2):e72.
58.
Lee K, Choe BH, Kang B, Kim S, Kim JY, Shim JO, Lee YM, Lee EH,
Jang HJ, Ryoo E, Yang HR. Nationwide Multicenter Study of Eosinophilic
Esophagitis in Korean Children. Pediatr Gastroenterol Hepatol Nutr.
2020;23(3):231-242.
57.
Turner D, Huang Y, Martin-de-Carpi J, Aloi M, Focht G, Kang B,
Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O,
Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of
ESPGHAN. Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases:
Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD
Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and
Nutrition. J Pediatr Gastroenterol Nutr. 2020;70(6):727-733.
56.
Choi SY, Choi YO, Choe YH, Kang B. Potential Utility of
Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal
Healing and Histologic Remission in Pediatric Crohn's Disease Patients. J
Korean Med Sci. 2020 Apr 27;35(16):e114.
55.
Kang B, Kim JE, Jung JH, Choe
JY, Kim MJ, Choe YH, Kim S, Koh H, Lee YM, Lee JH, Lee Y, Lee JH, Lee HJ, Jang
HJ, Choi Y, Choi SY, Kim JY, Choe BH. Korean Children and
Adolescents with Crohn's Disease Are More Likely to Present with Perianal
Fistulizing Disease at Diagnosis Compared to Their European Counterparts.
Pediatr Gastroenterol Hepatol Nutr. 2020;23(1):49-62.
54. Cozijnsen MA, Ben
Shoham A, Kang B, Choe BH,
Choe YH, Jongsma MM, Russell RK, Ruemmele FM, Escher JC, de Ridder L, Koletzko
S, Martin-de-Carpi J, Hyams J, Walters T, Griffiths A, Turner D. Development
and Validation of the Mucosal Inflammation Non-invasive Index For Pediatric
Crohn's Disease. Clin Gastroenterol Hepatol. 2020;18(1):133-140.e1.
53.
Choe JY, Jang KM, Min SY, Hwang SK, Kang B, Choe BH. Propionic
Acidemia with Novel Mutation Presenting as Recurrent Pancreatitis in a Child. J
Korean Med Sci. 2019;34(47):e303.
52. Kang B. Can proton pump inhibitors cause intestinal
inflammation in children
Korean J Pediatr. 2019;62(10):384-385.
51. Choi SY, Kang B, Choe YH. Serum
Infliximab Cutoff Trough Level Values for Maintaining Hematological Remission
in Pediatric Inflammatory Bowel Disease. Gut Liver. 2019;13(5):541-548.
50. Kang B, Choi SY, Choi YO, Lee
SY, Baek SY, Sohn I, Choe BH, Lee HJ, Choe YH. Infliximab Trough Levels Are
Associated With Mucosal Healing During Maintenance Treatment With Infliximab in
Paediatric Crohn's Disease. J Crohns Colitis. 2019;13(2):189-197.
49. Kim ES, Kwon
KT, Kim SK, Kim M, Lee HS, Jang BI, Kim KO, Kim EY, Lee YJ, Hong SJ, Yang CH, Kang B, Choe BH; Crohn’s and
Colitis Association in Daegu-Gyeongbuk (CCAiD). Impact of Education on School
Nurses' Knowledge of Inflammatory Bowel Disease. Gut Liver. 2019;13(1):48-53.
48. Kim HA, Suh
HR, Kang B, Choe BH. Acute
pancreatitis associated with indigo naturalis in pediatric severe Crohn's
disease. Intest Res. 2019;17(1):144-148.
47. Jang HJ, Kang B, Choe BH. The difference
in extraintestinal manifestations of inflammatory bowel disease for children
and adults. Transl Pediatr. 2019;8(1):4-15.
46. Kim S, Park S,
Kang Y, Kim JE, Kang B, Choe
BH, Lee YJ, Park JH, Yang HR, Lee SH, Kim KM, Ryoo E, Tchah H, Shim JO, Koh H. Can
We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients
An Asian Multicenter Study. J Pediatr Gastroenterol Nutr. 2019;68(1):45-49.
45. Yi DY, Kim SC,
Lee JH, Lee EH, Kim JY, Kim YJ, Kang KS, Hong J, Shim JO, Lee Y, Kang B, Lee YJ, Kim MJ, Moon JS,
Koh H, You J, Kwak YS, Lim H, Yang HR. Clinical Practice Guideline for the
Diagnosis and Treatment of Pediatric Obesity: Recommendations from the
Committee on Pediatric Obesity of the Korean Society of Pediatric
Gastroenterology Hepatology and Nutrition. Pediatr Gastroenterol Hepatol Nutr.
2019;22(1):1-27.
44. Yi DY, Kim SC,
Lee JH, Lee EH, Kim JY, Kim YJ, Kang KS, Hong J, Shim JO, Lee Y, Kang B, Lee YJ, Kim MJ, Moon JS,
Koh H, You J, Kwak YS, Lim H, Yang HR. Clinical practice guideline for the
diagnosis and treatment of pediatric obesity: recommendations from the
Committee on Pediatric Obesity of the Korean Society of Pediatric
Gastroenterology Hepatology and Nutrition. Korean J Pediatr. 2019;62(1):3-21.
43. Jang HM, Baek
HS, Kim JE, Kim JY, Lee YH, Cho HY, Choe YH, Kang B, Choe BH, Choi BS, Cho MH. Renal involvement in
children and adolescents with inflammatory bowel disease. Korean J Pediatr.
2018;61(10):327-331.
42. Choi SY, Kang B, Choe JY, Lee Y, Jang HJ,
Park HD, Lee SK, Choe YH. A Case of Glycogen Storage Disease IV with Rare
Homozygous Mutations in the Glycogen Branching Enzyme Gene. Pediatr
Gastroenterol Hepatol Nutr. 2018;21(4):365-368.
41. Kang B, Choi SY, Choi YO, Kim
MJ, Kim K, Lee JH, Choe YH. Subtherapeutic Infliximab Trough Levels and
Complete Mucosal Healing Are Associated With Sustained Clinical Remission After
Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated With
Combined Immunosuppressive Therapy. J Crohns Colitis. 2018;12(6):644-652.
40. Choi J, Kang B, Kim MJ, Sohn I, Lee HJ,
Choe YH. Early Infliximab Yields Superior Long-Term Effects on Linear Growth in
Pediatric Crohn's Disease Patients. Gut Liver. 2018;12(3):255-262.
39. Hong SJ, Cho
SM, Choe BH, Jang HJ, Choi KH, Kang B,
Kim JE, Hwang JH. Characteristics and Incidence Trends for Pediatric
Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center
Study. J Korean Med Sci. 2018;33(18):e132.
38. Kook SY, Kim
Y, Kang B, Choe YH, Kim YH,
Kim S. Characterization of the fecal microbiota differs between age groups in
Koreans. Intest Res. 2018;16(2):246-254.
37. Kang B, Lee Y, Lee K, Choi YO,
Choe YH. Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset
Inflammatory Bowel Disease: A Single-Center Prospective Observational Study. Inflamm
Bowel Dis. 2018;24(3):607-616.
36. Kang B,
Choe YH. Early Biologic Treatment in Pediatric Crohn’s Disease: Catching the
Therapeutic Window of Opportunity in Early Disease by Treat-to-Target. Pediatr
Gastroenterol Hepatol Nutr. 2018;21:1-11.
35.
Choe JY, Ko JS, Choe BH, Kim JE, Kang
B, Lee KJ, Yang HR. Antiviral Efficacy of Tenofovir Monotherapy in
Children with Nucleos(t)ide-naive Chronic Hepatitis B. J Korean Med Sci. 2018
Jan 8;33(2):e11.
34.
Yang A, Kang B, Choe JY, Kim
HS, Kim K, Choe YH. Prevalence and Epidemiological Characteristics of Endoscopically
Proven Reflux Esophagitis in Children in Korea. Pediatr Gastroenterol Hepatol
Nutr. 2017;20(3):160-166.
33.
Kim H, Park J, Kang B, Kwon
Y. Clinical Characteristics of Status Epilepticus as the First Presentation of
Fever Related Seizure in Children. J Korean Child Neurol Soc. 2017;25(2):82-88.
32.
Song WJ, Kang B, Lee HP, Cho
J, Lee HJ, Choe YH. Pediatric Mycoplasma pneumoniae Infection Presenting with
Acute Cholestatic Hepatitis and Other Extrapulmonary Manifestations in the
Absence of Pneumonia. Pediatr Gastroenterol Hepatol Nutr. 2017;20(2):124-129.
31.
Kim HT, Choi R, Won HH, Choe YH, Kang
B, Lee K, Koo HH, Yoo KH, Kim YH, Lee SY. NUDT15 genotype distributions
in the Korean population. Pharmacogenet Genomics. 2017;27(5):197-200.
30. Kang B, Choi SY, Chi S, Lim Y,
Jeon TY, Choe YH. Baseline Wall Thickness Is Lower in Mucosa-Healed Segments 1
Year After Infliximab in Pediatric Crohn Disease Patients. J Pediatr
Gastroenterol Nutr. 2017;64(2):279-285.
29. Choi SY, Kang B, Lee JH, Choe YH. Clinical
Use of Measuring Trough Levels and Antibodies against Infliximab in Patients
with Pediatric Inflammatory Bowel Disease. Gut Liver. 2017;11(1):55-61.
28. Kang B, Choi SY, Kim HS, Kim K,
Lee YM, Choe YH. Mucosal Healing in Paediatric Patients with Moderate-to-Severe
Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus
Early Treatment. J Crohns Colitis. 2016;10(11):1279-1286.
27. Song WJ, Kang B, Choi SY, Choe YH. Adalimumab
Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure:
A Single Center Study. Pediatr Gastroenterol Hepatol Nutr. 2016;19(2):116-22.
26.
Choi R, Park HD, Kang B, Choi
SY, Ki CS, Lee SY, Kim JW, Song J, Choe YH. PHKA2 mutation spectrum in Korean
patients with glycogen storage disease type IX: prevalence of deletion
mutations. BMC Med Genet. 2016;17:33.
25. Kang B, Kim DH, Hong YJ, Son BK,
Lim MK, Choe YH, Kwon YS. Complete occlusion of the right middle cerebral
artery associated with Mycoplasma pneumoniae pneumonia. Korean J Pediatr.
2016;59(3):149-52
24.
Hwang SM, Jeon TY, Yoo SY, Kim JH, Kang
B, Choe YH, Cho H, Kim JS. Alagille Syndrome Candidates for Liver
Transplantation: Differentiation from End-Stage Biliary Atresia Using
Preoperative CT. PLoS One. 2016;11(2):e0149681.
23.
Kim HJ, Kang B, Joo EY, Kim
EY, Kwon YS. Peripheral facial palsy, the only presentation of a primitive
neuroectodermal tumor of the skull base. Int J Surg Case Rep. 2016;19:47-50.
22.
Choi MR, Kang B, Kwon YS. A
Case of Progressive Multifocal Leukoencephalopathy in a 10-year-old Girl. J
Korean Child Neurol Soc 2015;23(2):71-74.
21. Lee MN, Kang B, Choi SY, Kim MJ, Woo SY,
Kim JW, Choe YH, Lee SY. Impact of Genetic Polymorphisms on 6-Thioguanine
Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with
Azathioprine. Inflamm Bowel Dis. 2015;21(12):2897-908.
20. Lee HP, Kang B, Choi SY, Lee S, Lee SK,
Choe YH. Outcome of Alagille Syndrome Patients Who Had Previously Received
Kasai Operation during Infancy: A Single Center Study. Pediatr Gastroenterol Hepatol
Nutr. 2015;18(3):175-9.
19. Yang A, Kang B, Choi SY, Cho JB, Kim YJ,
Jeon TY, Choe YH. Acute Necrotizing Pancreatitis Associated with Mycoplasma
pneumoniae Infection in a Child. Pediatr Gastroenterol Hepatol Nutr.
2015;18(3):209-15.
18.
Kang B, Choe YH. Author's
Response. J Pediatr Gastroenterol Nutr. 2015;61(3):e15.
17. Lee YM, Kang B, Lee Y, Kim MJ, Choe YH. Infliximab
"Top-Down" Strategy is Superior to "Step-Up" in Maintaining
Long-Term Remission in the Treatment of Pediatric Crohn Disease. J Pediatr
Gastroenterol Nutr. 2015;60(6):737-43.
16. Lee MN, Kang B, Choi SY, Kim MJ, Woo SY,
Kim JW, Choe YH, Lee SY. Relationship between azathioprine dosage,
6-thioguanine nucleotide levels, and therapeutic response in pediatric patients
with IBD treated with azathioprine. Inflamm Bowel Dis. 2015;21(5):1054-62.
15. Kim HY, Lee
SH, Lee MN, Kim JW, Kim YH, Kim MJ, Lee YM, Kang B, Choe YH, Lee NH, Kim DH, Yoo KH, Sung KW, Lee SY,
Koo HH. Complete sequence-based screening of TPMT variants in the Korean population.
Pharmacogenet Genomics. 2015;25(3):143-6.
14. Jung SY, Kang B, Choi YM, Kim JM, Kim SK,
Kwon YS, Lee JE. Development of multifocal nodular lesions of a liver mimicking
hepatic metastasis, following resection of an insulinoma in a child. Korean J
Pediatr. 2015;58(2):69-72.
13. Jeong YJ, Kang B, Choi SY, Ki CS, Lee SY,
Park HD, Choe YH. Does type I truly dominate hepatic glycogen storage diseases
in Korea
: a single center study. Pediatr Gastroenterol Hepatol Nutr.
2014;17(4):239-47.
12. Kim HY, Kim JW,
Kim MJ, Lee YM, Kang B, Choe
YH, Lee SY. Safe azathioprine treatment in a pediatric ulcerative colitis
patient with TPMT*16 by thiopurine metabolite monitoring. Clin Chim Acta.
2014;437:101-2.
11. Kang B, Kwon YS. Benign
convulsion with mild gastroenteritis. Korean J Pediatr. 2014;57(7):304-9.
10. Kim JM, Lee
YM, Kang B, Choe YH. Clinical
course of infliximab treatment in korean pediatric ulcerative colitis patients:
a single center experience. Pediatr Gastroenterol Hepatol Nutr.
2014;17(1):31-6.
9. Kim KS, Kim YH,
Hwang Y, Kang B, Kim DH, Kwon
YS. Epileptic nystagmus and vertigo associated with bilateral temporal and
frontal lobe epilepsy. Clin Exp Otorhinolaryngol. 2013;6(4):259-62.
8. Lee MN, Woo HI,
Lee YM, Kang B, Kim JW, Choe
YH, Lee SY. Successful azathioprine treatment with metabolite monitoring in a
pediatric inflammatory bowel disease patient homozygous for TPMT*3C. Yonsei Med
J. 2013;54(6):1545-9.
7. Chun JY, Kang B, Lee YM, Lee SY, Kim MJ,
Choe YH. Adverse events associated with azathioprine treatment in korean
pediatric inflammatory bowel disease patients. Pediatr Gastroenterol Hepatol
Nutr. 2013;16(3):171-7.
6. Kang B, Kim DH, Hong YJ, Son BK,
Kim DW, Kwon YS. Comparison between febrile and afebrile seizures associated
with mild rotavirus gastroenteritis. Seizure. 2013;22(7):560-4.
5. Kang B, Jung SY, Kim SK, Lee JE,
Son BK, Kwon YS. Clinical Features of Seizures Related to Rickets in Breastfed
Children. J Korean Child Neurol Soc. 2012;20(3):179-87.
4. Cho SD, Kang B, Park SH, Sung HU, Jun
YH, Hong YJ, Son BK, Kwon YS. The Comparative Analysis of Bacterial and Aseptic
Meningitis in Neonates. J Korean Child Neurol Soc. 2012;20(1):1-8.
3. Kang B, Oh SK, Son BK, Kwon YS,
Lim MK, Choi YM, Choi SJ. A Case of a Human
Tail Without Associated Anomalies. J Korean Child Neurol Soc.
2011;19(3):287-91.
2. Kang B, Sung HU, Kim BK, Park
SY, Kim SK, Kwon YS, Lim MK, Lee JE. A Case of Turner Syndrome Associated with
Idiopathic Central Diabetes Insipidus. J Korean Soc Pediatr Endocrinol.
2011;16(1):56-60.
1. Choi EH, Kang B, Lee HY, Kang HS, Kim JH,
Lim DH, Son BK. Development of a
Questionnaire to Investigate the Level of Awareness of Allergic Rhinitis. Pediatr
Allergy Respir Dis. 2010;20(3):188-96.